Human Immunodeficiency Virus/Hepatits C Virus Coinfection in Spain: Elimination Is Feasible, but the Burden of Residual Cirrhosis Will Be SignificantJuan Berenguer, Manuel Márquez, Arturo Artero et al.|Open Forum Infectious Diseases|2018Cited by 28
Very low level viraemia and risk of virological failure in treated <scp>HIV</scp>‐1‐infected patientsRamón Teira, Francesc Vidal, Pepa Muñoz-Sánchez et al.|HIV Medicine|2016Cited by 23
Dyslipidaemia in HIV-infected women on antiretroviral therapy. Analysis of 922 patients from the Spanish VACH cohortVicente Estrada, Ignacio Suárez-Lozano, Paloma Geijo et al.|BMC Women s Health|2011Cited by 15
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIVRamón Teira, Juan Berenguer, Helena Díaz-Cuervo et al.|PLoS ONE|2021Cited by 10
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish CohortRamón Teira, Adrián Curran, Helena Díaz-Cuervo et al.|Infectious Diseases and Therapy|2022Cited by 6